EMA official links AstraZeneca vaccine and thrombosis

AstraZeneca's share price was down 2.14 percent at the start of London trading on Monday.

FILE: Several European countries have halted its use over fears the vaccine is causing blood clots. AFP/Andrew Yates

AFP/Andrew Yates

ROME - A top official in the European Medicines Agency said in an interview published Tuesday that there is a link between the AstraZeneca coronavirus vaccine and blood clots.

"In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction," EMA head of vaccines Marco Cavaleri told Italy's Il Messaggero newspaper.

He said that "in the next few hours, we will say that there is a connection, but we still have to understand how this happens".

READ: COVID-19: 452 new cases, 8 more deaths

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population have undermined confidence in the beleaguered vaccine.

After several countries suspended the use of the jab -- including Italy -- the EMA declared that the benefits outweigh the risks and it should remain in use.

But it has said that a causal link between clots and the vaccine is possible, and is expected to provide an updated assessment this week.

"We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine," Cavaleri said.

READ: Paris medics fear worst of COVID-19 wave still to come

He added: "Among the vaccinated, there are more cases of cerebral thrombosis... among young people than we would expect."

Source
AFP

Paid Content